Advertisement

Related Videos

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Welcome and Introduction to Vi3C

Advertisement

Advertisement




Jul
09
Today In Oncology
GLP-1 Receptor Agonists Linked to Lower Colorectal Cancer Risk in Patients With IBD
Intraoperative Margin Assessment With Specimen PET/CT Imaging in Early Breast Cancer
No Survival Benefit From Chemoradiotherapy After D2 Gastrectomy in Gastric Cancer
All-Oral Combination of Revumenib, Decitabine/Cedazuridine, and Venetoclax for Relapsed or Refractory AML
Investigators Identify Resistance Mechanism to Tagraxofusp Among Patients With BPDCN
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo